Bloomberg Technology
Moderna Co-Founder Calls Omicron a Major Threat
Moderna co-founder and Flagship Pioneering founder Noubar Afeyan joins Emily Chang to discuss the latest on the Omicron Covid-19 variant, what we know so far, and the process involved in developing a new targeted vaccine.
Bloomberg Technology
Apple Already Developing Higher-End HomeView
Apple’s new HomeView has been a long time coming – but now, Apple is already developing a higher-end version of the device with a robotic limb, which can automatically swivel the screen toward whoever is speaking. Bloomberg’s Mark Gurman joins Ed Ludlow with the details from this week’s Power On newsletter on “Bloomberg Tech.” ——–…
Bloomberg Technology
Hamilton Lane: AI’s Biggest Returns Have Been Private
Hamilton Lane Executive Co-Chairman Erik Hirsch says much of the wealth created by the AI boom has so far accrued in the private markets, as companies stay private longer and tap increasingly deep pools of capital. With exposure to OpenAI and Anthropic through its venture and growth relationships, Hirsch discusses how investors can access private…
Bloomberg Technology
Anthropic, Musk Offer Competing Visions for Sharing AI Wealth
Anthropic plans to dedicate 5% of its shares to a public benefit fund, offering its own approach to sharing the potential wealth created by AI as concerns grow about AI-driven labor disruption. Bloomberg’s Mike Shepard discusses how the plan differs from proposals for a government-run fund – and from Elon Musk’s pledge to give every…
Why Application-Level Permissions Won’t Secure AI Agents With Okta’s & NanoCo | Disrupt 2026
So You’ve Got a Hit Product. How Does Your Company Do It Again? | Disrupt 2026
Can You Still Build a Breakout Company Without AI? Investors and a Founder Weigh In | Disrupt 2026
Nitya Subramanian: Products and Protocol
Sleep Expert Answers Questions From Twitter ???? | Tech Support | WIRED
Ways you can help Black Lives Matter movement (links, orgs, and more) ????????
Why Application-Level Permissions Won’t Secure AI Agents With Okta’s & NanoCo | Disrupt 2026
So You’ve Got a Hit Product. How Does Your Company Do It Again? | Disrupt 2026
Can You Still Build a Breakout Company Without AI? Investors and a Founder Weigh In | Disrupt 2026
-
Science & Technology6 years agoNitya Subramanian: Products and Protocol
-
People & Blogs5 years agoSleep Expert Answers Questions From Twitter ???? | Tech Support | WIRED
-
CNET6 years agoWays you can help Black Lives Matter movement (links, orgs, and more) ????????
-
Wired7 years agoHow This Guy Became a World Champion Boomerang Thrower | WIRED
-
Wired7 years agoNeuroscientist Explains ASMR’s Effects on the Brain & The Body | WIRED
-
Wired7 years agoWhy It’s Almost Impossible to Solve a Rubik’s Cube in Under 3 Seconds | WIRED
-
Wired7 years agoFormer FBI Agent Explains How to Read Body Language | Tradecraft | WIRED
-
Entertainment6 years agoFormer CIA Chief of Disguise Breaks Down Cold War Spy Gadgets | WIRED
Mikha Rlin
November 29, 2021 at 11:43 pm
Of course he would. It’s all about the bottom line
S O
November 30, 2021 at 12:02 am
Stop listening to big Pharma and the media, the doctor who discovered the variant has stated that the symptoms were very mild and did not need any hospitalization..
Solomon Oyefeso
November 30, 2021 at 12:04 am
He is about to make billions
The Nation of Israel
November 30, 2021 at 12:34 am
Pablo Escobar is thrilled that his cocaina is still relevant.
Quiet Jagung
November 30, 2021 at 12:39 am
Money, money, money.